Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N E Davidson

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2013
Associations between adjuvant endocrine therapy and onset of physical and emotional concerns among breast cancer survivorsG J van Londen, E B Beckjord, M A Dew, et al.
British Journal of Cancer|August 14, 2014
EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trialH Cheng, K Ballman, M Vassilakopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 3, 2012
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozoleP E Goss, J N Ingle, S Martino, et al.
Breast Cancer Research and Treatment|February 2, 2018
Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studiesE Rakovitch, R Gray, F L Baehner, et al.
British Journal of Cancer|November 15, 2000
Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cellsE van der Wall, T Horn, E Bright, et al.
Journal of Hematotherapy|October 1, 1996
Comparative analysis of breast cancer contamination in mobilized and nonmobilized hematopoietic graftsA A Ross, T J Layton, A B Ostrander, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2008
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17J N Ingle, D Tu, J L Pater, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Breast CancerR W Carlson, B O Anderson, W Bensinger, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1997
Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomesL P Jacobson, B C Zhang, Y R Zhu, et al.
British Journal of Cancer|August 14, 2014
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100B P Schneider, L Li, F Shen, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2013
Associations between adjuvant endocrine therapy and onset of physical and emotional concerns among breast cancer survivorsG J van Londen, E B Beckjord, M A Dew, et al.
British Journal of Cancer|August 14, 2014
EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trialH Cheng, K Ballman, M Vassilakopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 3, 2012
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozoleP E Goss, J N Ingle, S Martino, et al.
Breast Cancer Research and Treatment|February 2, 2018
Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studiesE Rakovitch, R Gray, F L Baehner, et al.
British Journal of Cancer|November 15, 2000
Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cellsE van der Wall, T Horn, E Bright, et al.
Journal of Hematotherapy|October 1, 1996
Comparative analysis of breast cancer contamination in mobilized and nonmobilized hematopoietic graftsA A Ross, T J Layton, A B Ostrander, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2008
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17J N Ingle, D Tu, J L Pater, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Breast CancerR W Carlson, B O Anderson, W Bensinger, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1997
Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomesL P Jacobson, B C Zhang, Y R Zhu, et al.
British Journal of Cancer|August 14, 2014
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100B P Schneider, L Li, F Shen, et al.
Pageof 13